4.2 Article

An adaptive biomarker basket design in phase II oncology trials

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Mathematical & Computational Biology

Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiers

Kentaro Takeda et al.

Summary: The basket trial is a novel clinical trial design that evaluates the effectiveness of a treatment in multiple cancer types simultaneously. By incorporating additional classifiers like biomarkers, the treatment effects can be categorized more accurately among different baskets. The constrained hierarchical Bayesian model for latent subgroups (CHBM-LS) allows adaptive information borrowing across baskets by identifying latent subgroups, ultimately improving the handling of heterogeneous treatment effects in basket trials.

STATISTICS IN MEDICINE (2022)

Article Mathematical & Computational Biology

RoBoT: a robust Bayesian hypothesis testing method for basket trials

Tianjian Zhou et al.

Summary: RoBoT is a novel Bayesian method proposed for data analysis and decision-making in phase II basket trials, using a formal Bayesian hypothesis testing framework. The method infers that baskets belong to different latent subgroups to avoid type I error inflation caused by excessive shrinkage. The operating characteristics of RoBoT are assessed through computer simulations and compared with existing methods.

BIOSTATISTICS (2021)

Article Mathematical & Computational Biology

Bayesian Hierarchical Modeling and Biomarker Cutoff Identification in Basket Trials

Guosheng Yin et al.

Summary: The article introduces a design method for determining the biomarker cutoff for identifying sensitive patients through continuous biomarker measurement and Bayesian hierarchical modeling, and validates its feasibility and practicality through real trial examples, extensive simulation studies, and sensitivity analyses. The simulation studies show that the design can accurately select biomarker-positive patients and may exhibit competitive improvement in terms of overall Type I error, power, and average sample number.

STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2021)

Article Health Care Sciences & Services

Bayesian cluster hierarchical model for subgroup borrowing in the design and analysis of basket trials with binary endpoints

Nan Chen et al.

STATISTICAL METHODS IN MEDICAL RESEARCH (2020)

Article Medicine, Research & Experimental

A Bayesian basket trial design using a calibrated Bayesian hierarchical model

Yiyi Chu et al.

CLINICAL TRIALS (2018)

Article Statistics & Probability

BLAST: Bayesian latent subgroup design for basket trials accounting for patient heterogeneity

Yiyi Chu et al.

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2018)

Article Mathematical & Computational Biology

Bayesian basket trial design with exchangeability monitoring

Brian P. Hobbs et al.

STATISTICS IN MEDICINE (2018)

Review Medicine, General & Internal

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

Janet Woodcock et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer

D. P. Carbone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Pharmacology & Pharmacy

Robust exchangeability designs for early phase clinical trials with multiple strata

Beat Neuenschwander et al.

PHARMACEUTICAL STATISTICS (2016)

Review Oncology

The Bayesian basket design for genomic variant-driven phase II trials

Richard Simon et al.

SEMINARS IN ONCOLOGY (2016)

Article Multidisciplinary Sciences

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review

Miranta Antoniou et al.

PLOS ONE (2016)

Editorial Material Oncology

Basket Trials and the Evolution of Clinical Trial Design in an Era of Genomic Medicine

Amanda J. Redig et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Mathematical & Computational Biology

Adaptive enrichment designs for clinical trials

Noah Simon et al.

BIOSTATISTICS (2013)

Article Medicine, Research & Experimental

Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials

Scott M. Berry et al.

CLINICAL TRIALS (2013)

Article Biotechnology & Applied Microbiology

Implementing personalized cancer genomics in clinical trials

Richard Simon et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Article Medicine, Research & Experimental

An adaptive Simon Two-Stage Design for phase 2 studies of targeted therapies

Cheryl L. Jones et al.

CONTEMPORARY CLINICAL TRIALS (2007)

Article Mathematical & Computational Biology

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes

PF Thall et al.

STATISTICS IN MEDICINE (2003)